Table 1.
Article and year | Methods: Interview (I) Focus Group (FG) Both | Barriers to care | Stigma | Physician role in patient care | Participants experiences | Pharmacist role: naloxone; patient engagement | Geographic Area |
---|---|---|---|---|---|---|---|
Alanis-Hirsh et al., 2016 | I | * | * | Oregon, California, Wisconsin | |||
Bailey et al., 2014 | I | * | Massachusetts, Pennsylvania, Washington | ||||
Bearnot et al., 2019 | I | * | Not specified | ||||
Chatterjee et al., 2018 | I | * | Massachusetts | ||||
Fleming et. al 2019 | FG | * | Texas | ||||
Fox et al., 2015 | I | * | * | * | New York | ||
Furst et al, 2013 | I | * | * | * | * | New York | |
Godersky et al, 2019 | Both | * | * | * | * | Northwest US | |
Gunn et al., 2016 | Both | * | * | New York | |||
Hatcher et al., 2018 | I | * | * | Not specified | |||
Heinz et al., 2010 | I | * | * | * | Maryland | ||
Hewell et al., 2017 | Both | * | * | * | Alaska | ||
Kang et al., 2019 | I | * | * | North Carolina | |||
Mathis et al., 2020 | I | * | Tennessee | ||||
Mitchell et al., 2011 | I | * | * | * | Not specified | ||
Peterson et al., 2010 | I | * | Maryland | ||||
Teruya et al., 2014 | I | * | * | * | Not specified | ||
Tofighi et al., 2019 | I | * | * | New York | |||
Velez et al., 2017 | I | * | Oregon | ||||
Wilson et al., 2018 | I | * | * | Pacific Northwest | |||
Yarborough et al., 2016 | I | * | * | California |